Apogee Therapeutics, Inc. (APGE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$74.76M2024: -$171.17M2025: -$227.45M-$227.45M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$227.45M-32.9%
2024-$171.17M-129.0%
2023-$74.76M